Dave Selkirk

Dave Selkirk is an accomplished executive in the clinical research and biotechnology sectors, currently serving as President of Clinical Research and Executive Vice President of Global Operations at ERGOMED since 2023. As the CEO and Founder of WhiteChurch Pharma & Biotech Consulting since 2020, Dave Selkirk specializes in sponsor-CRO collaboration, decentralized clinical trial models, and operational optimization. Previous roles include Chief Operating Officer at Innovaderm Research Inc. and various leadership positions at Covance and PAREXEL International, demonstrating extensive expertise in alliance management, late-phase research, and client satisfaction. Dave Selkirk holds a BSc (Hon) in Biology and a certificat de français pratique from Western University.